Sophie Bustany, Julie Cahu, Géraldine Descamps, Catherine Pellat-Deceunynck, Brigitte Sola. Heat shock factor 1 is a potent therapeutic target for enhancing the efficacy of treatments for multiple myeloma with adverse prognosis.
Journal of Hematology and Oncology, BioMed Central, 2015, 8 (1), pp.40.
⟨10.1186/s13045-015-0135-3⟩.
⟨inserm-01237704⟩